ICON plc/$ICLR
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.
Ticker
$ICLR
Sector
Primary listing
Employees
39,900
Headquarters
Dublin, Ireland
Website
ICON plc Metrics
BasicAdvanced
$14B
19.01
$9.73
1.20
-
Price and volume
Market cap
$14B
Beta
1.2
52-week high
$294.91
52-week low
$125.10
Average daily volume
977K
Financial strength
Current ratio
1.294
Quick ratio
1.238
Long term debt to equity
36.81
Total debt to equity
37.121
Interest coverage (TTM)
5.77%
Profitability
EBITDA (TTM)
1,551.101
Gross margin (TTM)
28.66%
Net profit margin (TTM)
9.82%
Operating margin (TTM)
14.43%
Effective tax rate (TTM)
2.91%
Revenue per employee (TTM)
$200,000
Management effectiveness
Return on assets (TTM)
4.35%
Return on equity (TTM)
8.30%
Valuation
Price to earnings (TTM)
19.01
Price to revenue (TTM)
1.855
Price to book
1.51
Price to tangible book (TTM)
-4.83
Price to free cash flow (TTM)
15.166
Free cash flow yield (TTM)
6.59%
Free cash flow per share (TTM)
12.202
Growth
Revenue change (TTM)
-2.91%
Earnings per share change (TTM)
13.11%
3-year revenue growth (CAGR)
2.16%
10-year revenue growth (CAGR)
17.93%
3-year earnings per share growth (CAGR)
56.56%
10-year earnings per share growth (CAGR)
11.23%
What the Analysts think about ICON plc
Analyst ratings (Buy, Hold, Sell) for ICON plc stock.
Bulls say / Bears say
Adjusted earnings per share for Q2 2025 reached $3.26, beating analyst estimates of $3.19, which triggered a 14.6% jump in after-hours trading and signals solid earnings performance and investor optimism (Investing.com)
Gross business wins climbed 10.6% sequentially in Q2 to $2.97 billion, and net bookings generated a book-to-bill ratio of 1.02, highlighting strong contract flow and a growing backlog (Investing.com)
The board increased the share repurchase program by $500 million to $1.0 billion after buying back $250 million worth of shares at an average price of $146, indicating solid cash generation and a commitment to shareholder returns (Investing.com)
Quarterly revenue of $2.02 billion was down 4.8% versus Q2 2024, indicating ongoing top-line pressure even with quarter-on-quarter improvement (Investing.com)
Full-year 2025 revenue guidance has been narrowed to $7.85–$8.15 billion, below the previous $8.05–$8.65 billion forecast, causing an 8% share drop over concerns about slower growth (Investing.com)
Jefferies lowered ICON’s price target to $252 from $275, pointing to cautious biopharma spending among top clients and an uneven biotech recovery as persistent growth headwinds (Investing.com)
Data summarised monthly by Lightyear AI. Last updated on 30 Sept 2025.
ICON plc Financial Performance
Revenues and expenses
ICON plc Earnings Performance
Company profitability
ICON plc News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for ICON plc stock?
ICON plc (ICLR) has a market cap of $14B as of October 20, 2025.
What is the P/E ratio for ICON plc stock?
The price to earnings (P/E) ratio for ICON plc (ICLR) stock is 19.01 as of October 20, 2025.
Does ICON plc stock pay dividends?
No, ICON plc (ICLR) stock does not pay dividends to its shareholders as of October 20, 2025.
When is the next ICON plc dividend payment date?
ICON plc (ICLR) stock does not pay dividends to its shareholders.
What is the beta indicator for ICON plc?
ICON plc (ICLR) has a beta rating of 1.2. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.